PPBT
Purple Biotech
PPBT
PPBT
15 hedge funds and large institutions have $240K invested in Purple Biotech in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
15
Holding in Top 10
–
Calls
$326K
Puts
$20K
Top Buyers
| 1 | +$63.3K | |
| 2 | +$44K | |
| 3 | +$20.3K | |
| 4 |
Morgan Stanley
New York
|
+$7.72K |
| 5 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$3.59K |
Top Sellers
| 1 | -$33K | |
| 2 | -$27.5K | |
| 3 | -$12K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.1K |